Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

키워드

참고문헌 (160)

1. Fischbach MA, "Antibiotics for emerging pathogens", Science, 325, pp.1089~1093 (2009)
2. McDonald LC, "An epidemic, toxin gene-variant strain of Clostridium difficile", N Engl J Med, 353, pp.2433~2441 (2005)
3. Dorman SE, "From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis", Nat Med, 13, pp.295~298 (2007)
4. Munoz-Price LS, "Acinetobacter infection", N Engl J Med, 358, pp.1271~1281 (2008)
5. Oliver A, "High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection", Science, 288, pp.1251~1254 (2000)
6. Lautenbach E, "Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes", Infect Control Hosp Epidemiol, 31, pp.47~53 (2010)
7. Garner MJ, "An assessment of antimicrobial resistant disease threats in Canada", PLoS One, 10 (2015)
8. Rosenthal VD, "International Nosocomial Infection Control Consortium (INICC)report, data summary of 36 countries, for 2004-2009", Am J Infect Control, 40, pp.396~407 (2012)
9. Schneider H, "Pseudomonas aeruginosa outbreak in a pediatric oncology care unit caused by an errant water jet into contaminated siphons", Pediatr Infect Dis J, 31, pp.648~650 (2012)
10. Nagao M, "Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit", J Hosp Infect, 79, pp.49~53 (2011)
11. Caselli D, "Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation", Haematologica, 95, pp.1612~1615 (2010)
12. Bergen PJ, "Pharmacokinetic", pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model, 2010, pp.54, 3783~3789
13. Johansen HK, "Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients", J Cyst Fibros, 7, pp.391~397 (2008)
14. Zavascki AP, "Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy", Expert Rev Anti Infect Ther, 8, pp.71~93 (2010)
15. Queenan AM, "Carbapenemases: the versatile beta-lactamases", Clin Microbiol Rev, 20, pp.440~458 (2007)
16. Kitao T, "Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-beta-lactamases and AAC(6’)-Iae in Japan", Int J Antimicrob Agents, 39, pp.518~521 (2012)
17. Poirel L, "Emergence of KPC-producing Pseudomonas aeruginosa in the United States", Antimicrob Agents Chemother, 54, pp.3072~ (2010)
18. Wang C, "A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase", J Antimicrob Chemother, 57, pp.1261~1262 (2006)
19. Lee K, "blaVIM-2 cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital", Antimicrob Agents Chemother, 46, pp.1053~1058 (2002)
20. Jovcic B, "Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia", Antimicrob Agents Chemother, 55, pp.3929~3931 (2011)
21. Potron A, "Plasmid-mediated transfer of the blaNDM-1 gene in Gram-negative rods", FEMS Microbiol Lett, 324, pp.111~116 (2011)
22. Yezli S, "The molecular basis of beta-lactamase production in Gram-negative bacteria from Saudi Arabia", J Med Microbiol, 64, pp.127~136 (2015)
23. Martins AF, "Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil", Infection, 35, pp.457~460 (2007)
24. Sevillano E, "First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii", Pathol Biol (Paris), 57, pp.493~495 (2009)
25. El Garch F, "OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosa", Antimicrob Agents Chemother, 55, pp.4828~4833 (2011)
26. Mendes RE, "Emergence and widespread dissemination of OXA-23, -24", 40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program, 2009, pp.63, 55~59
27. Voor In ‘t Holt AF, "A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa", Antimicrob Agents Chemother, 58, pp.2626~2637 (2014)
28. Yoneyama H, "Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa", Antimicrob Agents Chemother, 37, pp.2385~2390 (1993)
29. Borgianni L, "Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States", Antimicrob Agents Chemother, 55, pp.140~145 (2011)
30. Hocquet D, "Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France", Antimicrob Agents Chemother, 54, pp.3512~3515 (2010)
31. Koh TH, "Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel blaIMP-26gene", J Clin Microbiol, 48, pp.2563~2564 (2010)
32. Quale J, "Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates", Antimicrob Agents Chemother, 50, pp.1633~1641 (2006)
33. Bradford PA, "Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat", Clin Microbiol Rev, 14, pp.933~951 (2001)
34. Jacoby GA, "The new beta-lactamases", N Engl J Med, 352, pp.380~391 (2005)
35. Walsh TR, "Clinically significant carbapenemases: an update", Curr Opin Infect Dis, 21, pp.367~371 (2008)
36. Partridge SR, "Gene cassettes and cassette arrays in mobile resistance integrons", FEMS Microbiol Rev, 33, pp.757~784 (2009)
37. Edelstein MV, "Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study", Lancet Infect Dis, 13, pp.867~876 (2013)
38. Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35, pp.147~151 (1991)
39. Lauretti L, "Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate", Antimicrob Agents Chemother, 43, pp.1584~1590 (1999)
40. Wachino J, "SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate", Antimicrob Agents Chemother, 55, pp.5143~5149 (2011)
41. El Salabi A, "Genetic and biochemical characterization of a novel metallo-beta-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya", Antimicrob Agents Chemother, 56, pp.2241~2245 (2012)
42. Potron A, "Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology", Int J Antimicrob Agents, 45, pp.568~585 (2015)
43. Willmann M, "Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study", J Antimicrob Chemother, 70, pp.1322~1330 (2015)
44. Walsh TR, "Metallo-beta-lactamases: the quiet before the storm?", Clin Microbiol Rev, 18, pp.306~325 (2005)
45. Nordmann P, "Emerging carbapenemases in Gram-negative aerobes", Clin Microbiol Infect, 8, pp.321~331 (2002)
46. Toleman MA, "Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme", J Antimicrob Chemother, 50, pp.673~679 (2002)
47. Gales AC, "Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase", J Antimicrob Chemother, 52, pp.699~702 (2003)
48. Salabi AE, "First report of the metallo-beta-lactamase SPM-1 in Europe", Antimicrob Agents Chemother, 54, pp.582~ (2010)
49. Jones RN, "Emerging epidemic of metallo-beta-lactamase-mediated resistances", Diagn Microbiol Infect Dis, 51, pp.77~84 (2005)
50. Toleman MA, "ISCR elements: novel gene-capturing systems of the 21st century?", Microbiol Mol Biol Rev, 70, pp.296~316 (2006)
51. Castanheira M, "Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase", Antimicrob Agents Chemother, 48, pp.4654~4661 (2004)
52. Wendel AF, "Genetic characterization and emergence of the metallo-beta-lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a long-term outbreak", Antimicrob Agents Chemother, 57, pp.5162~5165 (2013)
53. Yong D, "Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India", Antimicrob Agents Chemother, 53, pp.5046~5054 (2009)
54. Flateau C, "Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012", Euro Surveill, 17, pp.20311~ (2012)
55. Janvier F, "Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France", Antimicrob Agents Chemother, 57, pp.3408~3411 (2013)
56. Khajuria A, "Emergence of NDM - 1 in the clinical isolates of Pseudomonas aeruginosa in India", J Clin Diagn Res, 7, pp.1328~1331 (2013)
57. Carattoli A, "Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013", Euro Surveill, 18, pp.20633~ (2013)
58. Zafer MM, "First report of NDM-1-producing Pseudomonas aeruginosa in Egypt", Int J Infect Dis, 29, pp.80~81 (2014)
59. Kulkova N, "First report of New Delhi metallo-beta-lactamase-1-producing strains in Slovakia", Microb Drug Resist, 21, pp.117~120 (2015)
60. Pollini S, "FIM-1, a new acquired metallo-beta-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy", Antimicrob Agents Chemother, 57, pp.410~416 (2013)
61. 정윤섭, "Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non- Typhoidal Salmonella Species", Infection and Chemotherapy, 46(2), pp.84~93 (2014), 대한감염학회
62. Poirel L, "Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmidand integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France", Antimicrob Agents Chemother, 44, pp.891~897 (2000)
63. Lee K, "VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", Emerg Infect Dis, 9, pp.868~871 (2003)
64. Lee K, "Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp", Diagn Microbiol Infect Dis, 50, pp.51~58 (2004)
65. Kyungwon Lee, "Metallo-β-Lactamase-Producing Pseudomonas spp. in Korea: High Prevalence of Isolates with VIM-2 Type and Emergence of Isolates with IMP-1 Type", Yonsei Medical Journal, 50(3), pp.335~339 (2009), 연세대학교의과대학
66. Seok Y, "Dissemination of IMP-6 metallo-beta-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea", J Antimicrob Chemother, 66, pp.2791~2796 (2011)
67. 홍준성, "Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea", Infection and Chemotherapy, 47(1), pp.33~40 (2015), 대한감염학회
68. Valenza G, "First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital", Antimicrob Agents Chemother, 54, pp.3493~3497 (2010)
69. Yano H, "Plasmid-encoded metallo-beta-lactamase (IMP-6)conferring resistance to carbapenems, especially meropenem", Antimicrob Agents Chemother, 45, pp.1343~1348 (2001)
70. Xu J, "Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study", PLoS One, 8 (2013)
71. Kakeya H, "A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital", Jpn J Antibiot, 67, pp.241~248 (2014)
72. Lee HS, "Antimicrobial consumption and resistance in five Gram-negative bacterial species in a hospital from 2003 to 2011", J Microbiol Immunol Infect (2014)
73. Kiratisin P, "Comparative in vitro activity of carbapenems against major Gram-negative pathogens:results of Asia-Pacific surveillance from the COMPACT II study", Int J Antimicrob Agents, 39, pp.311~316 (2012)
74. Mendes RE, "Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)", Antimicrob Agents Chemother, 57, pp.5721~5726 (2013)
75. Farajzadeh Sheikh A, "Detection of metallo-beta lactamases among carbapenem-resistant Pseudomonas aeruginosa", Jundishapur J Microbiol, 7 (2014)
76. Castanheira M, "Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries", J Antimicrob Chemother, 69, pp.1804~1814 (2014)
77. Mansour SA, "Epidemiological characterization of P. aeruginosa isolates of intensive care units in Egypt and Saudi Arabia", East Mediterr Health J, 19, pp.71~80 (2013)
78. Liakopoulos A, "Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons", BMC Infect Dis, 13, pp.505~ (2013)
79. Sefraoui I, "Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012", Microb Drug Resist, 20, pp.156~161 (2014)
80. Pitout JD, "Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya", Clin Microbiol Infect, 14, pp.755~759 (2008)
81. Brink A, "Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa", S Afr Med J, 97, pp.273~279 (2007)
82. Mataseje LF, "Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP)", J Antimicrob Chemother, 67, pp.1359~1367 (2012)
83. Morfin-Otero R, "Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010", BMC Res Notes, 5, pp.277~ (2012)
84. Perez F, "Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio", Antimicrob Agents Chemother, 58, pp.5929~5935 (2014)
85. Toval F, "Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-beta-lactamases in a major hospital in Costa Rica", J Med Microbiol, 64, pp.37~43 (2015)
86. Labarca JA, "Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America", Crit Rev Microbiol (2014)
87. Mano Y, "Molecular analysis of the integrons of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan", BMC Microbiol, 15, pp.41~ (2015)
88. Qu TT, "Evaluation of phenotypic tests for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains in China", J Clin Microbiol, pp.1136~1142 (2009)
89. Ozgumus OB, "Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey", Microb Drug Resist, 13, pp.191~198 (2007)
90. Koh TH, "Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore", J Clin Microbiol, 42, pp.5378~5380 (2004)
91. Boonkerd N, "Class 1 integron containing metallo beta-lactamase gene blaIMP-1 in carbapenem-resistant Pseudomonas aeruginosa in Thailand", J Infect Chemother, 15, pp.257~261 (2009)
92. Fallah F, "Detection of blaIMP and blaVIM metallo-beta-lactamases genes among Pseudomonas aeruginosa strains", Int J Burns Trauma, 3, pp.122~124 (2013)
93. Shibata N, "PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron", J Clin Microbiol, 41, pp.5407~5413 (2003)
94. Bert F, "IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia: impact of early detection and control measures", Clin Infect Dis, 44, pp.764~765 (2007)
95. Peleg AY, "Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia", Clin Infect Dis, 41, pp.1549~1556 (2005)
96. Hawkey PM, "Occurrence of a new metallo-beta-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People’s Republic of China", FEMS Microbiol Lett, 194, pp.53~57 (2001)
97. Brízio A, "High-level expression of IMP-5 carbapenemase owing to point mutation in the -35 promoter region of class 1 integron among Pseudomonas aeruginosa clinical isolates", Int J Antimicrob Agents, 27, pp.27~31 (2006)
98. Ryoo NH, "Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital", Diagn Microbiol Infect Dis, 63, pp.115~117 (2009)
99. Chen Y, "Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China", Eur J Clin Microbiol Infect Dis, 33, pp.1181~1187 (2014)
100. Gibb AP, "Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7", Antimicrob Agents Chemother, 46, pp.255~258 (2002)
101. Ho SE, "Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase", Antimicrob Agents Chemother, 46, pp.3286~3287 (2002)
102. Ohlasova D, "First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia", Int J Antimicrob Agents, 30, pp.370~371 (2007)
103. Kouda S, "First isolation of blaIMP-7 in a Pseudomonas aeruginosa in Japan", J Infect Chemother, 13, pp.276~277 (2007)
104. Hrabák J, "First identification of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Czech Republic", Euro Surveill, 14, pp.19102~ (2009)
105. Hammerum AM, "Characterisation of an IMP-7-producing ST357 Pseudomonas aeruginosa isolate detected in Denmark using whole genome sequencing", Int J Antimicrob Agents, 45, pp.200~201 (2015)
106. Xiong J, "blaIMP-9 and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People’s Republic of China", Antimicrob Agents Chemother, 50, pp.355~358 (2006)
107. Lim KT, "Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia", J Microbiol Immunol Infect, 42, pp.197~209 (2009)
108. Iyobe S, "Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain", Antimicrob Agents Chemother, 46, pp.2014~2016 (2002)
109. Zhao WH, "Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa", J Med Microbiol, 58, pp.1080~1085 (2009)
110. Duljasz W, "First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria", Antimicrob Agents Chemother, 53, pp.2221~2222 (2009)
111. Pagani L, "Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase", J Clin Microbiol, 43, pp.3824~3828 (2005)
112. Fournier D, "Spread of the blaIMP-13 gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111", Int J Antimicrob Agents, 40, pp.571~573 (2012)
113. Naas T, "Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium", J Antimicrob Chemother, 66, pp.2178~2179 (2011)
114. Piyakul C, "Emergence of metallo-beta-lactamase IMP-14 and VIM-2 in Pseudomonas aeruginosa clinical isolates from a tertiary-level hospital in Thailand", Epidemiol Infect, 140, pp.539~541 (2012)
115. Quinones-Falconi F, "Emergence of Pseudomonas aeruginosa strains producing metallo-beta-lactamases of the IMP-15 and VIM-2 types in Mexico", Clin Microbiol Infect, 16, pp.126~131 (2010)
116. Gilarranz R, "First detection in Europe of the metallo-beta-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa", Clin Microbiol Infect, 19, pp.E424~E427 (2013)
117. Mendes RE, "Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6’)-30", aac(6’)-Ib’: report from the SENTRY Antimicrobial Surveillance Program, 2004, pp.48, 4693~4702
118. Hanson ND, "First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18", Antimicrob Agents Chemother, 50, pp.2272~2273 (2006)
119. Garza-Ramos U, "Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico", Int J Antimicrob Agents, 31, pp.78~80 (2008)
120. Wolter DJ, "Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases", Antimicrob Agents Chemother, 53, pp.1660~1664 (2009)
121. Pollini S, "Acquisition of plasmid-borne blaIMP-19 gene by a VIM-1-positive Pseudomonas aeruginosa of the sequence type 235 epidemic lineage", J Antimicrob Chemother, 68, pp.722~724 (2013)
122. Pellegrini C, "Identification of blaIMP-22 in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location", J Antimicrob Chemother, 63, pp.901~908 (2009)
123. Kim MJ, "Dissemination of metallo-beta-lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries", J Antimicrob Chemother, 68, pp.2820~2824 (2013)
124. Jeannot K, "IMP-29, a novel IMP-type metallo-beta-lactamase in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 56, pp.2187~2190 (2012)
125. Pegg KM, "Biochemical characterization of IMP-30, a metallo-beta-lactamase with enhanced activity toward ceftazidime", Antimicrob Agents Chemother, 57, pp.5122~5126 (2013)
126. Pfennigwerth N, "Description of IMP-31, a novel metallo-beta-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany", J Antimicrob Chemother (2015)
127. Deshpande LM, "IMP-33, a New IMP variant detected in Pseudomonas aeruginosa from Sicily", Antimicrob Agents Chemother, 57, pp.6401~6403 (2013)
128. Pournaras S, "Detection of a phylogenetically distinct IMP-type metallo-beta-lactamase, IMP-35, in a CC235 Pseudomonas aeruginosa from the Dutch-German border region (Euregio)", J Antimicrob Chemother, 68, pp.1271~1276 (2013)
129. Tada T, "IMP-43 and IMP-44 metallo-beta-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa", Antimicrob Agents Chemother, 57, pp.4427~4432 (2013)
130. Wang Y, "IMP-45-producing multidrug-resistant Pseudomonas aeruginosa of canine origin", J Antimicrob Chemother, 69, pp.2579~2581 (2014)
131. Corvec S, "Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France", Clin Microbiol Infect, 12, pp.941~942 (2006)
132. Tsakris A, "Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1carbapenemase in Greece", J Clin Microbiol, 38, pp.1290~1292 (2000)
133. Mansour W, "Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia", Diagn Microbiol Infect Dis, 64, pp.458~461 (2009)
134. Castanheira M, "Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18)", Antimicrob Agents Chemother, 53, pp.1225~1227 (2009)
135. Libisch B, "Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary", Res Microbiol, 159, pp.162~168 (2008)
136. Khosravi Y, "Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11", Diagn Microbiol Infect Dis, 67, pp.294~296 (2010)
137. Yatsuyanagi J, "Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan", Antimicrob Agents Chemother, 48, pp.626~628 (2004)
138. Poirel L, "Carbapenem-hydrolyzing metallo-beta-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France", Emerg Infect Dis, 6, pp.84~85 (2000)
139. Poole K, "Overcoming multidrug resistance in gram-negative bacteria", Curr Opin Investig Drugs, 4, pp.128~139 (2003)
140. Pallecchi L, "Molecular heterogeneity of blaVIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase", FEMS Microbiol Lett, 195, pp.145~150 (2001)
141. Cardoso O, "Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal", Microb Drug Resist, 8, pp.93~97 (2002)
142. Prats G, "First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain", Antimicrob Agents Chemother, 46, pp.932~933 (2002)
143. Sardelic S, "Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia", Emerg Infect Dis, 9, pp.1022~1023 (2003)
144. Walsh TR, "Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program", J Antimicrob Chemother, 52, pp.116~119 (2003)
145. Zafer MM, "Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt", BMC Infect Dis, 15, pp.122~ (2015)
146. Yan JJ, "Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme", Antimicrob Agents Chemother, 45, pp.2224~2228 (2001)
147. Libisch B, "Isolation of an integron-borne blaVIM-4 type metallo-beta-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary", Antimicrob Agents Chemother, 48, pp.3576~3578 (2004)
148. Castanheira M, "Dissemination and genetic context analysis of blaVIM-6among Pseudomonas aeruginosa isolates in Asian-Pacific Nations", Clin Microbiol Infect, 16, pp.186~189 (2010)
149. Toleman MA, "blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States", Antimicrob Agents Chemother, 48, pp.329~332 (2004)
150. Crespo MP, "Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia", J Clin Microbiol, 42, pp.5094~5101 (2004)
151. Woodford N, "Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom", J Antimicrob Chemother, 62, pp.1265~1268 (2008)
152. Marchiaro P, "Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain", Antimicrob Agents Chemother, 52, pp.2250~2252 (2008)
153. Juan C, "Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain", Antimicrob Agents Chemother, 52, pp.3589~3596 (2008)
154. Mazzariol A, "A novel VIMtype metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit", Clin Microbiol Infect, 17, pp.722~724 (2011)
155. Schneider I, "VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany", Antimicrob Agents Chemother, 52, pp.2977~2979 (2008)
156. Siarkou VI, "Molecular epidemiology of outbreak-related Pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene", Antimicrob Agents Chemother, 53, pp.1325~1330 (2009)
157. Riera E, "Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem", J Antimicrob Chemother, 66, pp.2022~2027 (2011)
158. El-Mahdy TS, "Identification of a novel metallo-beta-lactamase VIM-28 located within unusual arrangement of class 1 integron structure in Pseudomonas aeruginosa isolates from Egypt", Jpn J Infect Dis, 67, pp.382~384 (2014)
159. Iraz M, "Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing beta-lactamases in Pseudomonas aeruginosa in Turkey", Diagn Microbiol Infect Dis, 78, pp.292~294 (2014)
160. Poirel L, "Molecular analysis of metallo-beta-lactamase gene blaSPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil", Antimicrob Agents Chemother, 48, pp.1406~1409 (2004)

관련 논문AI추천